
Alpha Profiles · Company Profile
Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United…
https://registry.alpha.ac/companies/arcturus-therapeutics-holdings-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: ARCT
- Verification
- Partially verified
- Last reviewed
- 2026-09-29T04:46:56.447267+00:00
Overview
Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by specific CFTR gene mutations.
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-09-29T04:46:56.447267+00:00
